"If we're going to be a serious port, then we've got to look at bringing in containers. The container changed the world. It's ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

One of the companies with a long-standing presence is Eli Lilly, and the company recently announced that it would double its investment on a manufacturing facility in Ireland. All told ...

Eli Lilly is just weeks away from launching Mounjaro ... for EU approval of the KwikPen format later this year. Northern Ireland still comes under the jurisdiction of the EU regulatory system.

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Conditions are getting a bit more challenging for the drugmaker.

Healthcare giant Eli Lilly (NYSE: LLY) has been trading at an inflated valuation for some time thanks to excitement around its diabetes and weight loss treatments, Mounjaro and Zepbound.

Eli Lilly's business is growing fast, but it wasn't enough for analysts and investors. It also slashed its earnings guidance for the year. The stock has been trading at a high valuation ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...